Skip to main content
. 2017 Nov 7;7:14634. doi: 10.1038/s41598-017-12660-5

Figure 1.

Figure 1

Identification and experimental validation of circulating/secretory miRNAs in SS-patient serum. (A) Schematic representation of the approach used for the detection of circulating/secretory miRNAs in SS-patients. (B) Heatmap and the hierarchical clustering of miRNA microarray analysis using patient serum in preoperative state as well as in cell culture media of SS cells. (C) Serum levels of the candidate markers in SS patients, age-matched benign tumour patients, and healthy individuals. *p < 0.05; Student’s t test. (D) Expression levels of candidate miRNAs in SS cells and human mesenchymal stem cells (hMSCs). Data are presented as mean ± S.D. (n = 3 in each group) *p < 0.05; Student’s t test. (E) Expression levels of candidate miRNA biomarkers in culture media of SS cells (SYO-1, YaFuSS, and HS-SY-II) and hMSCs. Data are presented as mean ± S.D. (n = 3 in each group) *p < 0.05; Student’s t test. (F) The expression dynamics of miR-92b-3p and miR-150-3p in the culture media of SS cell lines according to cell number and the culture duration. Data are presented as mean ± S.D. (n = 3 in each group) *p < 0.05; Student’s t test.